Answer
The pressârelease you referenced announces that BrainStormâŻCell Therapeutics (ticker BCLI) will hold a conference call on AugustâŻ14,âŻ2025 to discuss its secondâquarter (Q2) results and give a corporate update. However, the excerpt you provided does not include the actual financial guidance figuresâi.e., the expected Q2 revenue, Q2 earnings (or earnings per share), nor the fullâyear revenue and earnings expectations.
What this means for your question
| Item | Guidance disclosed in the excerpt? | What we can infer |
|---|---|---|
| Q2 revenue expectation | No specific amount mentioned. | Not available from the provided text. |
| Q2 earnings (or EPS) expectation | No specific amount mentioned. | Not available from the provided text. |
| Fullâyear (2025) revenue expectation | No specific amount mentioned. | Not available from the provided text. |
| Fullâyear (2025) earnings (or EPS) expectation | No specific amount mentioned. | Not available from the provided text. |
How to obtain the missing numbers
- Read the full pressârelease â The complete PRNewswire announcement (usually available on the companyâs investorârelations website or the PRNewswire site) will list the guidance numbers in a âFinancial Outlookâ or âGuidanceâ section.
- Check the SEC filing â If BrainStorm has filed a FormâŻ8âK or a similar disclosure around the same date, the guidance will be included there.
- Listen to the conference call â The call scheduled for AugustâŻ14,âŻ2025 will typically repeat the guidance figures and may provide additional context.
Bottom line
Based solely on the information you supplied, we cannot specify the revenue or earnings expectations for Q2 or the full year. To answer the question definitively, youâll need to locate the complete pressârelease or the accompanying SEC filing where BrainStorm Cell Therapeutics outlines its financial outlook.